Literature DB >> 19577062

Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years.

Daniëlle Robbers-Visser1, Livia Kapusta, Lennie van Osch-Gevers, Jan L M Strengers, Eric Boersma, Yolanda B de Rijke, Frans Boomsma, Ad J J C Bogers, Willem A Helbing.   

Abstract

OBJECTIVE: This study assessed clinical condition at midterm follow-up after total cavopulmonary connection for a functionally univentricular heart performed on children younger than 5 years.
METHODS: Thirty-four Fontan patients (median age 10.4 years, range 6.8-20.7 years, 22 boys, median follow-up 7.8 years, 5.0-17.8 years) underwent electrocardiography, Holter monitoring, bicycle exercise testing, cardiac magnetic resonance imaging, and N-terminal prohormone brain natriuretic peptide (NT-pro-BNP) analysis.
RESULTS: Twenty-three patients (68%) were in sinus rhythm. Holter monitoring demonstrated normal mean heart rate, low maximal heart rate, and no clinically significant arrhythmias or sinus node dysfunction. With maximal bicycle ergometry (n = 19), maximum workload (60% of normal), maximum heart rate (90% of normal), and maximal oxygen uptake (69% of normal) were all significantly lower in the Fontan group than in a control group (P < .001). Variables of submaximal exercise indicated less efficient oxygen uptake during exercise in all Fontan patients. Ejection fraction was lower than in control subjects (59% +/- 13% vs 69% +/- 5%, P < .001). Mean end-diastolic and end-systolic volumes and ventricular mass were higher than in control subjects (P < .001). Mean NT-pro-BNP levels were increased relative to reference values, but only 8 patients had levels above the upper reference limit.
CONCLUSION: At midterm follow-up, Fontan patients were in acceptable clinical condition, with preserved global ventricular function, moderately decreased exercise capacity, and NT-pro-BNP levels within reference range. Systemic ventricular mass was elevated, however, suggesting contractility-afterload mismatch. Long-term consequences for ventricular function merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577062     DOI: 10.1016/j.jtcvs.2008.12.027

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  High Overweight and Obesity in Fontan Patients: A 20-Year History.

Authors:  Stephanie T Chung; Borah Hong; Lance Patterson; Christopher J Petit; J Nina Ham
Journal:  Pediatr Cardiol       Date:  2015-09-16       Impact factor: 1.655

2.  Peak circulatory power as an indicator of clinical status in children after Fontan procedure.

Authors:  Nitin Madan; Lisa Beachler; Pantelis Konstantinopoulos; Sarah Worley; Zhiyuan Sun; Larry A Latson
Journal:  Pediatr Cardiol       Date:  2010-10-19       Impact factor: 1.655

3.  Comparative Noninvasive Measurement of Cardiac Output Based on the Inert Gas Rebreathing Method (Innocor®) and MRI in Patients with Univentricular Hearts.

Authors:  Miriam Kuhn; Andreas Hornung; Heidi Ulmer; Christian Schlensak; Michael Hofbeck; Gesa Wiegand
Journal:  Pediatr Cardiol       Date:  2018-02-03       Impact factor: 1.655

Review 4.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

5.  A novel Fontan Y-graft for interrupted inferior vena cava and azygos continuation.

Authors:  S Samaneh Lashkarinia; Murat Cicek; Banu Kose; Mohammad Rezaeimoghaddam; Emine Hekim Yılmaz; Numan Ali Aydemir; Reza Rasooli; Sercin Ozkok; Nurgul Yurtseven; Hasan Erdem; Kerem Pekkan; Ahmet Sasmazel
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

6.  Stress increases intracardiac 4D flow cardiovascular magnetic resonance -derived energetics and vorticity and relates to VO2max in Fontan patients.

Authors:  Vivian P Kamphuis; Mohammed S M Elbaz; Pieter J van den Boogaard; Lucia J M Kroft; Hildo J Lamb; Mark G Hazekamp; Monique R M Jongbloed; Nico A Blom; Willem A Helbing; Arno A W Roest; Jos J M Westenberg
Journal:  J Cardiovasc Magn Reson       Date:  2019-07-25       Impact factor: 5.364

7.  Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.

Authors:  Eva van den Bosch; Sjoerd S M Bossers; Vivian P Kamphuis; Eric Boersma; Jolien W Roos-Hesselink; Johannes M P J Breur; Arend D J Ten Harkel; Livia Kapusta; Beatrijs Bartelds; Arno A W Roest; Irene M Kuipers; Nico A Blom; Laurens P Koopman; Willem A Helbing
Journal:  J Am Heart Assoc       Date:  2021-02-24       Impact factor: 5.501

8.  Aortopulmonary collateral flow is related to pulmonary artery size and affects ventricular dimensions in patients after the fontan procedure.

Authors:  Heiner Latus; Kerstin Gummel; Tristan Diederichs; Anna Bauer; Stefan Rupp; Gunter Kerst; Christian Jux; Hakan Akintuerk; Dietmar Schranz; Christian Apitz
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

9.  Longitudinal Myocardial Deformation Does Not Predict Single Ventricle Ejection Fraction Assessed by Cardiac Magnetic Resonance Imaging in Children with a Total Cavopulmonary Connection.

Authors:  L P Koopman; L M Geerdink; S S M Bossers; N Duppen; I M Kuipers; A D Ten Harkel; G van Iperen; G Weijers; C de Korte; W A Helbing; L Kapusta
Journal:  Pediatr Cardiol       Date:  2017-10-25       Impact factor: 1.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.